internal
Joaquin Duato
Chairman and Chief Executive Officer
Executive
4 yr
9 reports
Johnson & Johnson ·JNJ
Two global business chairmen run J&J’s operating divisions
Pharmaceuticals · Fortune #41 · Divisional structure · 132K employees · New Brunswick, NJ
9
CEO span
↓ tighter than peers (avg 10)
1
Avg span
tight
2
Max depth
flat for 132K emp
3.1 yr
Avg tenure
78%
Internal hires
↑ above industry avg
Consolidated financials FY2025 · period end 2025-12-28 · 10-K
Revenue
$94.2B
Operating income
$21.6B
Net income
$26.8B
Total assets
$199.2B
Shares out
2.41B
Interactive org chart
Johnson & Johnson organizational chart
Explore the executive structure, reporting layers, and scenario-ready operating model from public filings.
Open editable chart
Take this model into your AI workspace Use AI to reason through the model, then bring the scenario back into Creately Atlas.
Choose a prompt, then open an AI app and paste.
Download the CSV data instead
Two worldwide chairmen control Johnson & Johnson’s entire operating footprint, an unusually concentrated design for a $90B healthcare company. This page maps J&J’s divisional structure, executive committee, leadership metrics, and recent governance changes.
What to model
Use the chart to test org decisions, not just view reporting lines
Start with the public baseline, then use the scenario views and source-backed changes to ask what happens when leadership, span, or team ownership shifts.
Latest signal John G. Morikis joined as Board Director
Elected to the Board on September 8, 2025.
Source · See change logScenario views in the chart
- Add a Chief Operating Officer Introduce a COO to coordinate Innovative Medicine and MedTech execution, reducing span on the CEO.
- Split Innovative Medicine leadership Divide Innovative Medicine into two business presidents to reduce concentration under one chair.
Atlas work this supports
- Connect Workday or UKG Get these analytics for YOUR org — tenure, span of control, headcount, automatically from your HRIS.
- Connect Salesforce Map your target accounts like this. Import contacts, visualize decision chains, plan multi-threading.
- Plan a Reorg Use this as a starting point. Model scenarios, compare structures, present options to your board.
The people
Who's running this
10 executives identified as Named Executive Officers in the most recent SEC proxy. Bar length scales with tenure.
internal
Jennifer L. Taubert
Executive Vice President, Worldwide Chairman, Innovative Medicine
Innovative Medicine
3 yr
0 reports
internal
Tim Schmid
Executive Vice President, Worldwide Chairman, MedTech
MedTech
2 yr
0 reports
internal
Joseph J. Wolk
Executive Vice President, Chief Financial Officer
Finance
3 yr
0 reports
internal
James Swanson
Executive Vice President, Chief Information Officer
Information Technology
4 yr
0 reports
internal
Kristen Mulholland
Executive Vice President, Chief Human Resources Officer
Human Resources
3 yr
0 reports
internal
Elizabeth Forminard
Executive Vice President, Chief Legal Officer
Legal
2 yr
0 reports
internal
Vanessa Broadhurst
Executive Vice President, Global Corporate Affairs
Corporate Affairs
1 yr
0 reports
John C. Reed
Executive Vice President, Innovative Medicine, R&D
Research & Development
4 yr
0 reports
internal
Kathryn E. Wengel
Executive Vice President, Chief Technical Operations and Risk Officer
Operations & Risk
5 yr
0 reports
The businesses
How Johnson & Johnson divides the work
3 divisions report into the group CEO. Tile size scales with estimated headcount.
Innovative Medicine
65K employees
Worldwide Chairman, Innovative Medicine (Jennifer L. Taubert)
Develops and commercializes prescription medicines across oncology, immunology, neuroscience and cardiopulmonary.
MedTech
45K employees
Worldwide Chairman, MedTech (Tim Schmid)
Designs and manufactures medical devices across cardiovascular, surgery, orthopaedics and vision.
Corporate Functions
22K employees
Chairman and CEO (Joaquin Duato)
Provides enterprise-wide governance, finance, legal, HR, IT, risk and external affairs.
The thesis
Why this org is unusual
Two worldwide chairmen run Johnson & Johnson’s operating engine.
Instead of regional or product-line presidents reporting to a COO, J&J places its Innovative Medicine and MedTech divisions under two EVP-level worldwide chairmen who report directly to the CEO. This concentrates P&L authority in just two roles while the rest of the Executive Committee is largely functional.
The structure reflects J&J’s post–Consumer Health simplification and its focus on scale science and devices. Functional leaders—finance, legal, HR, IT, corporate affairs and technical operations—do not own divisional P&Ls, reinforcing a clean split between business execution and enterprise governance. Notably, J&J operates without a COO, unusual for a company of its size.
This design reduces matrix complexity at the top but places heavy execution demands on the two worldwide chairmen, making succession and depth beneath them strategically critical.
- No Chief Operating Officer
- Two worldwide chairmen hold all operating P&Ls
- Functional leaders dominate remaining CEO reports
The comparison
How Johnson & Johnson stacks up
Compared with large pharma peers like Pfizer and Merck, Johnson & Johnson is more centralized at the top, with fewer divisional CEOs. Pfizer and Novartis typically operate multiple business unit heads with narrower scopes. J&J’s model more closely resembles a holding-style enterprise with two super-divisions …
C-suite size
Reporting depth
Johnson & Johnson
2 levels
5 levels
5 levels
Abbott Laboratories
5 levels
Medtronic
6 levels
Avg C-suite tenure
Has COO / Has CAIO
Johnson & Johnson — no COO — no CAIO
Abbott Laboratories ✓ COO — no CAIO
Medtronic ✓ COO — no CAIO
Current signals
What changed recently
Johnson & Johnson refreshed its board in 2025 with the additions of John Morikis and Daniel Pinto.
- new
- new
Frequently Asked Questions
Who is the CEO of Johnson & Johnson?
Joaquin Duato has served as Chairman and Chief Executive Officer since 2022.
What type of organizational structure does Johnson & Johnson use?
Johnson & Johnson uses a divisional structure centered on Innovative Medicine and MedTech.
How many direct reports does Johnson & Johnson's CEO have?
The CEO has nine direct reports, mostly functional leaders plus two worldwide business chairmen.
How has Johnson & Johnson's leadership changed recently?
In 2025, the company added two new independent directors, John Morikis and Daniel Pinto.
Does Johnson & Johnson have a COO?
No. Johnson & Johnson operates without a Chief Operating Officer, with operations led by two worldwide chairmen.
Sources
- 8-K Filing, Sep 2025
- 8-K Filing, Jun 2025
- SEC EDGAR: Johnson & Johnson DEF 14A Proxy Statement
- SEC EDGAR: Johnson & Johnson 10-K Annual Report
Reference
Cite this page
If you reference this page in research, analysis, or news writing, use one of the formats below. Citation includes the SEC filing source where applicable.
APA 7th
Creately. (2026). Johnson & Johnson organizational structure. Creately. Retrieved , from https://creately.com/org-chart/fortune-500/johnson-and-johnson/MLA 9th
"Johnson & Johnson Organizational Structure." Creately, April 1, 2026, https://creately.com/org-chart/fortune-500/johnson-and-johnson/. Accessed .Chicago 17
Creately. "Johnson & Johnson Organizational Structure." Last modified April 1, 2026. https://creately.com/org-chart/fortune-500/johnson-and-johnson/.Permanent URL: https://creately.com/org-chart/fortune-500/johnson-and-johnson/ · last updated 2026-04-01